Edit Symbol List
Enter up to 25 symbols separated by commas or spaces in the text box below. These symbols will be available during your session for use on applicable pages.
Don't know the stock symbol? Use the symbol lookup tool.
Alphabetize the sort order of my symbols
ETFs with AMGN as a Top 10 Holding*
|Weighting||ETF Name (Symbol)||100-Day Price Change (%)|
|11.51%||Merrill Lynch Biotech HOLDRS (BBH)||+2.37 (2.85%)|
|8.94%||iShares NASDAQ Biotechnology Index Fund (IBB)||+11.66 (5.52%)|
|5.39%||PowerShares Dynamic Biotech &Genome (PBE)||+3.61 (10.14%)|
|5.17%||PowerShares Dynamic Pharmaceuticals (PJP)||+3.59 (6.97%)|
|5.11%||First Trust Amex Biotechnology Index Fund (FBT)||+7.26 (11.10%)|
**Green highlights the top performing ETF by % change in the past 100 days.
Company Description (as filed with the SEC)
Amgen Inc. (including its subsidiaries, referred to as “Amgen,” “the Company,” “we,” “our” or “us”) is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology. Amgen focuses on areas of high unmet medical need and leverages its biologics manufacturing expertise to strive for solutions that improve health outcomes and dramatically improve people's lives. A biotechnology pioneer, Amgen has grown to be the world's largest independent biotechnology company, has reached millions of patients around the world and is developing a pipeline of medicines with breakaway potential. We were incorporated in California in 1980 and became a Delaware corporation in 1987. ... More ...